The move comes after a series of cuts to prevention and treatment efforts worldwide. Some functions might be moved to another ...

Annie Antar, MD, PhD, discusses how patients with HIV can have different and longer-lasting symptoms of COVID-19.

In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the ...

After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding.

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Mayor Daniel Lurie signed an executive order aimed at consolidating services he thinks are not doing enough to help the ...

Textbooks usually depict the epithelial cells encasing the interior and exterior of your body as passive barriers. But researchers discovered they can produce electrical signals like neurons.

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

The House of Representatives narrowly passed a budget resolution, which Malliotakis voted in favor of, late last month.